• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.细胞类型特异性融合辅助因子决定了1型人类免疫缺陷病毒对T细胞系与原代巨噬细胞的嗜性。
J Virol. 1996 Aug;70(8):5487-94. doi: 10.1128/JVI.70.8.5487-5494.1996.
2
Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages.
Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):9004-8. doi: 10.1073/pnas.92.19.9004.
3
CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.CC趋化因子受体5:作为嗜巨噬细胞性HIV-1融合辅助因子的RANTES、巨噬细胞炎性蛋白-1α、巨噬细胞炎性蛋白-1β受体
Science. 1996 Jun 28;272(5270):1955-8. doi: 10.1126/science.272.5270.1955.
4
HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.与高度适应巨噬细胞的包膜相比,HIV-1非巨噬细胞嗜性R5包膜糖蛋白对进入原代CD4+T细胞的嗜性并不更强。
Retrovirology. 2015 Mar 14;12:25. doi: 10.1186/s12977-015-0141-0.
5
CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity.猿猴免疫缺陷病毒包膜蛋白(Envs)的CD4非依赖性与巨噬细胞嗜性、中和敏感性及致病性减弱相关。
J Virol. 2002 Mar;76(6):2595-605. doi: 10.1128/jvi.76.6.2595-2605.2002.
6
Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.CXCR4在原代人类免疫缺陷病毒1型(HIV-1)毒株介导的单核细胞衍生巨噬细胞的细胞间融合及感染中的作用:HIV-1双嗜性的两种不同机制
J Virol. 1999 Sep;73(9):7117-25. doi: 10.1128/JVI.73.9.7117-7125.1999.
7
A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.一种参与嗜T细胞的1型人类免疫缺陷病毒株融合与进入的七跨膜结构域受体。
J Virol. 1996 Sep;70(9):6288-95. doi: 10.1128/JVI.70.9.6288-6295.1996.
8
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.嗜巨噬细胞性HIV和SIV包膜蛋白通过CCR5趋化因子受体诱导信号。
Nature. 1997 Oct 30;389(6654):981-5. doi: 10.1038/40173.
9
HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.HIV-1 R5嗜巨噬细胞性包膜糖蛋白三聚体以高亲和力结合CD4,而非巨噬细胞嗜性、T嗜性R5包膜上的CD4结合位点则被封闭。
J Virol. 2018 Jan 2;92(2). doi: 10.1128/JVI.00841-17. Print 2018 Jan 15.
10
Phenotypic Correlates of HIV-1 Macrophage Tropism.HIV-1巨噬细胞嗜性的表型关联
J Virol. 2015 Nov;89(22):11294-311. doi: 10.1128/JVI.00946-15. Epub 2015 Sep 2.

引用本文的文献

1
Co-receptor signaling in the pathogenesis of neuroHIV.共受体信号在神经 HIV 发病机制中的作用。
Retrovirology. 2021 Aug 24;18(1):24. doi: 10.1186/s12977-021-00569-x.
2
Cell Proteins Interacting with the Human Immunodeficiency Virus in Immunoblotting can be Detected by R5- or X4- Tropic Human Immunodeficiency Virus Particles.在免疫印迹中与人类免疫缺陷病毒相互作用的细胞蛋白可通过R5或X4嗜性人类免疫缺陷病毒颗粒检测到。
Int J Appl Basic Med Res. 2020 Apr-Jun;10(2):81-85. doi: 10.4103/ijabmr.IJABMR_398_18. Epub 2020 Apr 2.
3
Immune Control of HIV.HIV的免疫控制
J Life Sci (Westlake Village). 2019 Jun;1(1):4-37.
4
Transmission, Evolution, and Endogenization: Lessons Learned from Recent Retroviral Invasions.传播、进化和内源性化:从最近的逆转录病毒入侵中吸取的教训。
Microbiol Mol Biol Rev. 2017 Dec 13;82(1). doi: 10.1128/MMBR.00044-17. Print 2018 Mar.
5
Hyaluronic Acid Conjugated Magnetic Prussian Blue@Quantum Dot Nanoparticles for Cancer Theranostics.用于癌症诊疗的透明质酸共轭磁性普鲁士蓝@量子点纳米颗粒
Theranostics. 2017 Jan 6;7(2):466-481. doi: 10.7150/thno.17411. eCollection 2017.
6
A Designed "Nested" Dimer of Cyanovirin-N Increases Antiviral Activity.一种设计的氰胍蛋白 - N“嵌套”二聚体可增强抗病毒活性。
Viruses. 2016 Jun 6;8(6):158. doi: 10.3390/v8060158.
7
Finding Fusin/CXCR4, the First "2nd Receptor" for HIV Entry.发现福斯因/趋化因子受体4(Fusin/CXCR4),即首个HIV进入的“第二受体”。
Front Immunol. 2015 Jun 8;6:283. doi: 10.3389/fimmu.2015.00283. eCollection 2015.
8
Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.HIV 相关神经认知障碍的遗传、转录组和表观遗传学研究。
J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):481-503. doi: 10.1097/QAI.0000000000000069.
9
Genetic diversity of the highly variable V1 region interferes with Human Immunodeficiency Virus type 1 envelope functionality.高度可变的 V1 区的遗传多样性会干扰人类免疫缺陷病毒 1 型包膜的功能。
Retrovirology. 2013 Oct 24;10:114. doi: 10.1186/1742-4690-10-114.
10
Engineered lentiviral vectors pseudotyped with a CD4 receptor and a fusogenic protein can target cells expressing HIV-1 envelope proteins.工程化的慢病毒载体,假型为 CD4 受体和融合蛋白,可靶向表达 HIV-1 包膜蛋白的细胞。
Virus Res. 2011 Sep;160(1-2):340-50. doi: 10.1016/j.virusres.2011.07.010. Epub 2011 Jul 23.

本文引用的文献

1
Redefinition of tropism of common macrophage-tropic human immunodeficiency virus type 1.常见巨噬细胞嗜性1型人类免疫缺陷病毒嗜性的重新定义。
AIDS Res Hum Retroviruses. 1995 Dec;11(12):1467-71. doi: 10.1089/aid.1995.11.1467.
2
CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.CC趋化因子受体5:作为嗜巨噬细胞性HIV-1融合辅助因子的RANTES、巨噬细胞炎性蛋白-1α、巨噬细胞炎性蛋白-1β受体
Science. 1996 Jun 28;272(5270):1955-8. doi: 10.1126/science.272.5270.1955.
3
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.HIV-1进入辅助因子:一种七跨膜G蛋白偶联受体的功能性cDNA克隆
Science. 1996 May 10;272(5263):872-7. doi: 10.1126/science.272.5263.872.
4
The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s).在表达人CD4的动物细胞中,人HIV-1包膜糖蛋白介导的膜融合障碍可被一种人细胞成分克服。
Virology. 1993 Mar;193(1):483-91. doi: 10.1006/viro.1993.1151.
5
In vitro differentiation of monocytoid THP-1 cells affects their permissiveness for HIV strains: a model system for studying the cellular basis of HIV differential tropism.单核细胞样THP-1细胞的体外分化影响其对HIV毒株的易感性:一种用于研究HIV差异嗜性细胞基础的模型系统。
Virology. 1993 Mar;193(1):256-67. doi: 10.1006/viro.1993.1121.
6
Infection of macrophages with lymphotropic human immunodeficiency virus type 1 can be arrested after viral DNA synthesis.用亲淋巴细胞性1型人类免疫缺陷病毒感染巨噬细胞后,病毒DNA合成后感染可被阻止。
J Virol. 1993 Nov;67(11):6893-6. doi: 10.1128/JVI.67.11.6893-6896.1993.
7
Early replication steps but not cell type-specific signalling of the viral long terminal repeat determine HIV-1 monocytotropism.病毒长末端重复序列的早期复制步骤而非细胞类型特异性信号传导决定了HIV-1对单核细胞的嗜性。
AIDS Res Hum Retroviruses. 1993 Jul;9(7):669-75. doi: 10.1089/aid.1993.9.669.
8
Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors.
Gene. 1994 May 16;142(2):167-74. doi: 10.1016/0378-1119(94)90257-7.
9
The "V3" domain is a determinant of simian immunodeficiency virus cell tropism.“V3”结构域是猿猴免疫缺陷病毒细胞嗜性的一个决定因素。
J Virol. 1994 Jun;68(6):3682-92. doi: 10.1128/JVI.68.6.3682-3692.1994.
10
Susceptibility of human-mouse T cell hybrids to HIV-productive infection.
AIDS Res Hum Retroviruses. 1993 Dec;9(12):1269-75. doi: 10.1089/aid.1993.9.1269.

细胞类型特异性融合辅助因子决定了1型人类免疫缺陷病毒对T细胞系与原代巨噬细胞的嗜性。

Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.

作者信息

Alkhatib G, Broder C C, Berger E A

机构信息

Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA.

出版信息

J Virol. 1996 Aug;70(8):5487-94. doi: 10.1128/JVI.70.8.5487-5494.1996.

DOI:10.1128/JVI.70.8.5487-5494.1996
PMID:8764060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC190506/
Abstract

Work in this laboratory previously demonstrated that the tropism of different human immunodeficiency type 1 isolates for infection of human CD4+ continuous cell lines (e.g., T-cell lines and HeLa-CD4 transformants) versus primary macrophages is associated with parallel intrinsic fusogenic specificities of the corresponding envelope glycoproteins (Envs). For T-cell line-tropic isolates, it is well established that the target cell must also contain a human-specific fusion cofactor(s) whose identity is unknown. In this study, we tested the hypothesis that the Env fusion specificities underlying T-cell line versus macrophage tropism are determined by distinct cell type-specific fusion cofactors. We applied a recombinant vaccinia virus-based reporter gene assay for Env-CD4-mediated cell fusion; the LAV and Ba-L Envs served as prototypes for T-cell line-tropic and macrophage-tropic isolates, respectively. We examined CD4+ promyeloctic and monocytic cell lines that are infectible by T-cell line-tropic isolates and become susceptible to macrophage-tropic strains only after treatment with differentiating agents. We observed parallel changes in fusion specificity: untreated cells supported fusion by the LAV but not the Ba-L Env, whereas cells treated with differentiating agents acquired fusion competence for Ba-L. These results suggest that in untreated cells, the block to infection by macrophage-tropic isolates is at the level of membrane fusion; furthermore, the differential regulation of fusion permissiveness for the two classes of Envs is consistent with the existence of distinct fusion cofactors. To test this notion directly, we conducted experiments with transient cell hybrids formed between CD4-expressing nonhuman cells (murine NIH 3T3) and different human cell types. Hybrids formed with HeLa cells supported fusion by the LAV Env but not by the Ba-L Env, whereas hybrids formed with primary macrophages showed the opposite specificity; hybrids formed between HeLa cells and macrophages supported fusion by both Envs. These results suggest the existence of cell type-specific fusion cofactors selective for each type of Env, rather than fusion inhibitors for discordant Env-cell combinations. Finally, analyses based on recombinant protein expression and antibody blocking did not support the proposals by others that the CD44 or CD26 antigens are involved directly in the entry of macrophage-tropic isolates.

摘要

本实验室先前的研究表明,不同的1型人类免疫缺陷病毒分离株对人类CD4⁺连续细胞系(如T细胞系和HeLa-CD4转化体)与原代巨噬细胞的感染嗜性,与相应包膜糖蛋白(Envs)平行的内在融合特异性相关。对于嗜T细胞系的分离株,已经明确靶细胞还必须含有一种身份未知的人类特异性融合辅助因子。在本研究中,我们检验了以下假设:嗜T细胞系与巨噬细胞嗜性背后的Env融合特异性由不同的细胞类型特异性融合辅助因子决定。我们应用了基于重组痘苗病毒的报告基因检测法来检测Env-CD4介导的细胞融合;LAV和Ba-L Envs分别作为嗜T细胞系和嗜巨噬细胞系分离株的原型。我们检测了可被嗜T细胞系分离株感染的CD4⁺早幼粒细胞系和单核细胞系,这些细胞系仅在经过分化剂处理后才对嗜巨噬细胞系毒株敏感。我们观察到融合特异性的平行变化:未处理的细胞支持LAV介导的融合,但不支持Ba-L Env介导的融合,而经分化剂处理的细胞获得了对Ba-L的融合能力。这些结果表明,在未处理的细胞中,嗜巨噬细胞系分离株的感染阻断发生在膜融合水平;此外,两类Env融合许可性的差异调节与不同融合辅助因子的存在一致。为了直接验证这一观点,我们用表达CD4的非人类细胞(小鼠NIH 3T3)与不同人类细胞类型形成的瞬时细胞杂种进行了实验。与HeLa细胞形成的杂种支持LAV Env介导的融合,但不支持Ba-L Env介导的融合,而与原代巨噬细胞形成的杂种表现出相反的特异性;HeLa细胞与巨噬细胞之间形成的杂种支持两种Env介导的融合。这些结果表明存在对每种Env具有选择性的细胞类型特异性融合辅助因子,而不是对不匹配的Env-细胞组合的融合抑制剂。最后,基于重组蛋白表达和抗体阻断的分析不支持其他人提出的CD44或CD26抗原直接参与嗜巨噬细胞系分离株进入的观点。